These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4968248)

  • 1. The effects of topical THIOTEPA on the recurrence rate of superficial bladder cancers.
    Drew JE; Marshall VF
    J Urol; 1968 Jun; 99(6):740-3. PubMed ID: 4968248
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of thiotepa, in local instillation, as a prophylactic treatment for recurrence of superficial tumors of the bladder].
    Toulouse J; Bouffier B; Etievent JP; Bittard M
    J Urol (Paris); 1983; 89(2):85-9. PubMed ID: 6408192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical thiotepa prophylaxis of superficial bladder cancer. A follow-up study.
    Fosså SD; Miller A; Stenwig AE
    Eur Urol; 1983; 9(4):207-10. PubMed ID: 6409615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical thiotepa in prevention of recurrence of bladder tumour.
    Ghosal SK; Sen DK
    J Indian Med Assoc; 1980 Nov; 75(9):173-4. PubMed ID: 6785360
    [No Abstract]   [Full Text] [Related]  

  • 5. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors.
    Veenema RJ; Dean AL; Uson AC; Roberts M; Longo F
    J Urol; 1969 May; 101(5):711-5. PubMed ID: 4976352
    [No Abstract]   [Full Text] [Related]  

  • 6. Thiotepa versus adriamycin versus cis-platinum in the intravesical prophylaxis of superficial bladder tumors.
    Llopis B; Gallego J; Mompó JA; Boronat F; Jiménez JF
    Eur Urol; 1985; 11(2):73-8. PubMed ID: 3924624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The recurrence after conservative therapy of bladder cancer. II: The intravesical instillation of anti-cancer drug for preventing recurrence (author's transl)].
    Saito K; Fukushima S; Takahashi Y; Takai S
    Nihon Hinyokika Gakkai Zasshi; 1980 May; 71(5):449-57. PubMed ID: 6774151
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoprophylaxis of superficial tumors of the bladder with thiotepa: long-term results].
    Durán R; Reina GR; Hontoria JM; Merino C; Olivier C; Carballido J
    Actas Urol Esp; 1989; 13(1):19-23. PubMed ID: 2496583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladder.
    Csellár M; Csontai A
    Int Urol Nephrol; 1979; 11(1):39-44. PubMed ID: 112079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer.
    Byar D; Blackard C
    Urology; 1977 Dec; 10(6):556-61. PubMed ID: 414402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early multiple-dose adjuvant thiotepa in the control of multiple and rapid T1 tumour neogenesis.
    England HR; Flynn JT; Paris AM; Blandy JP
    Br J Urol; 1981 Dec; 53(6):588-92. PubMed ID: 6797501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical thiotepa in the treatment of transitional cell bladder carcinoma.
    Mitchell RJ
    Br J Urol; 1971 Apr; 43(2):185-8. PubMed ID: 4996214
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of intravesical thiotepa in superficial bladder tumours.
    Kulkarni JN; Kamat MR; Juvekar RL
    Indian J Cancer; 1981 Sep; 18(3):222-4. PubMed ID: 6796504
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer.
    Br J Urol; 1994 Jun; 73(6):632-8. PubMed ID: 8032829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of treatment methods for the prophylaxis of recurrent superficial bladder tumors.
    Rodrigues Netto Júnior N; Lemos GC
    J Urol; 1983 Jan; 129(1):33-4. PubMed ID: 6402610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma.
    Burnand KG; Boyd PJ; Mayo ME; Shuttleworth KE; Lloyd-Davies RW
    Br J Urol; 1976 Feb; 48(1):55-9. PubMed ID: 817761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical chemotherapy and chemoprevention of superficial, low grade, low stage bladder carcinoma.
    Koontz WW
    Semin Oncol; 1979 Jun; 6(2):217-9. PubMed ID: 113878
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cytostatic prophylactic treatment of superficial bladder tumours].
    Lunglmayr G
    Urologe A; 1972 Mar; 11(2):94-7. PubMed ID: 4623214
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Adjuvant intravesical thiotepa and bladder tumour recurrence.
    Boyd PJ; Burnand KG
    Br J Surg; 1975 Feb; 62(2):162. PubMed ID: 803851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.